You can order this product on prescription after adding it in your basket on checkout .
Sunekos 1200 2 x 15ml vials zoom

Hover

Sunekos ® 1200 zoom

Hover

Sunekos ® 1200 zoom

Hover

Sunekos ® 1200 zoom

Hover

Sunekos ® 1200 zoom

Hover

Sunekos 1200 2 x 15ml vials
Sunekos ® 1200
Sunekos ® 1200
Sunekos ® 1200
Sunekos ® 1200
Full Screen
Sunekos

Sunekos ® 1200

In Stock

£72.00( excl. VAT )

Want it delivered by Tomorrow? Order by 3pm
Order within 0h 0m 0s

£72.00( excl. VAT )

Let’s talk on WhatsApp

Sunekos® 1200 (2 × 1.5 mL) is a high-concentration hyaluronic acid and amino acid biostimulation injectable designed to support dermal density and treat moderate to advanced skin laxity. Unlike traditional dermal fillers, it focuses on stimulating collagen and elastin synthesis rather than providing mechanical volume. Used within structured treatment protocols, Sunekos 1200 is intended exclusively for professional aesthetic practice.

Description

Sunekos® 1200 (2 × 1.5 mL Vials)

Sunekos® 1200 is an injectable medical device formulated with a high concentration of hyaluronic acid combined with a specific amino acid complex. Developed by Professional Dietetics S.p.A., this formulation is designed for dermal biostimulation and structural extracellular matrix support in areas requiring enhanced tissue density.

Compared with Sunekos 200 (Performa), Sunekos 1200 contains a higher HA concentration (1200 mg per vial set) and is positioned for treatment of areas with more advanced laxity or volume loss. It is not intended as a traditional volumising dermal filler but rather as a biostimulatory injectable supporting collagen and elastin synthesis.

What Sunekos® 1200 Is Similar To

Sunekos 1200 can be regarded alongside other biostimulation injectables designed to improve dermal density and elasticity rather than provide structural filling. Compared with cross-linked hyaluronic acid fillers, it uses non-cross-linked HA combined with amino acids to support natural tissue regeneration.

In clinical discussions, queries such as “sunekos 1200 injection points” or “sunekos 1200 how to use” relate to its structured intradermal application protocol. Unlike volumising fillers, its effect is based on matrix stimulation rather than mechanical lift. This comparison is provided for clinical orientation only and does not imply interchangeability.

Treatment Areas / Indications

According to manufacturer documentation, Sunekos 1200 is indicated for dermal biostimulation and treatment of moderate to advanced skin laxity.

Treatment areas may include:
Face • Neck • Décolletage • Areas of structural dermal thinning

→ Sunekos 1200 is intended for intradermal or deep dermal placement depending on indication and practitioner assessment.

Usage / Administration (IFU-only)

Injection depth: Intradermal to deep dermal, depending on treatment area.
Volume per point / injection site: Not provided by manufacturer in public documentation.
Needle specification: Refer to packaging.
Frequency / number of sessions: Treatment protocols vary; refer to official IFU guidance.
Professional-use disclaimer: Administered only by qualified medical professionals under aseptic conditions.

If any parameter is omitted in the official IFU, it is marked as “not provided by manufacturer.”

Ingredient List

Hyaluronic acid (high concentration, as per manufacturer formulation)

Amino acid complex (including glycine, L-proline, L-lysine, L-alanine, and L-valine)

Sterile water for injection

Other excipients as per IFU.

Lidocaine: Not included.

Presentation & Longevity

Presentation: 2 × 1.5 mL sterile vials
Shelf-life: Refer to packaging for expiry date.
Longevity (treatment duration): Results vary depending on treatment protocol, patient condition, and maintenance schedule; not specified in public documentation.

Safety Notes / Contraindications

Use is contraindicated in patients with known hypersensitivity to hyaluronic acid or any component of the formulation.

Avoid use in patients with active infection or inflammation at the injection site.

Do not inject intravascularly.

Proper anatomical knowledge and controlled injection technique are essential.

Single use per vial; ensure packaging is intact and within expiry.

Regulatory Status

CE-marked medical device in Europe.
UKCA status: verify via IFU or authorised distributor.
Regulatory classification may vary by jurisdiction; confirm on packaging or manufacturer documentation.

FAQ

1. What is Sunekos 1200 used for?
Sunekos 1200 is used for dermal biostimulation and treatment of moderate to advanced skin laxity, supporting collagen and elastin production.

2. What are Sunekos 1200 injection points?
Injection points depend on treatment area and practitioner assessment. The manufacturer specifies intradermal or deep dermal placement; exact mapping should follow official IFU guidance.

3. How is Sunekos 1200 different from Sunekos 200?
Sunekos 1200 contains a higher concentration of hyaluronic acid and is typically selected for areas requiring enhanced dermal support compared with Sunekos 200.

4. How long do results last?
Longevity varies depending on protocol and patient factors. Maintenance sessions may be recommended based on clinical evaluation.

5. What does “Sunekos 1200 price” refer to?
Searches for “sunekos 1200 price” generally relate to product purchasing through authorised medical distributors; pricing varies by region and supplier.

0/5 (0 Reviews)

FAQs

No Faq found.

Shop By Brand

We stock, the industries favourite brands for all aesthetic practices. Explore what these top brands have to offer.